| Company/Division name | Alnylam Pharmaceuticals |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Kept from Offshoring |
| Total number of jobs (added or to be added): | 150 |
| Year reshoring announced: | 2016 |
| Capital investment ($): | 55 |
| City reshored to: | Norton |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Novel Therapeutics |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Skilled workforce availability/training |
| Government Incentive dollar amount: | $2.25 Million |
